Please select the option that best describes you:
What are your top takeaways in Neuro Oncology from ASTRO 2024?
Answer from: Radiation Oncologist at Community Practice
A Prospective, Phase II study of 177Lu-Dotatate in patients with surgery- and radiation-refractory meningioma: Results of the WHO grade II/III cohort, presented by Kenneth Merrell. I have spent a large portion of my career emphasizing optimal management for meningioma patients and this study opens...
Sign in or Register to read more